Recently, Par-4 has been shown to down-regulate NF-κB signaling through inhibition of p65 (also known as RelA; a subunit of NF-κB transcription complex) nuclear translocation and impedes leukemogenesis in an in vivo leukemia model39 (Fig. 2B). This evidence concerns the gene RELA and leukemia.